DexCom, Inc. Stock price

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2023-12-01 pm EST			5-day change	1st Jan Change
116.62 ^USD	+0.95%		+3.25%	+2.98%

Nov. 29	Transcript : DexCom, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-29-2023 08:30 AM	CI
Nov. 17	Wall Street: still positive bias ahead of the '3 Witches	CF

Latest news about DexCom, Inc.

Transcript : DexCom, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-29-2023 08:30 AM	Nov. 29	CI
Wall Street: still positive bias ahead of the '3 Witches	Nov. 17	CF
Wall Street: still positive bias on '3 Witches' Eve	Nov. 16	CF
Dexcom Insider Sold Shares Worth $101,256, According to a Recent SEC Filing	Nov. 16	MT
Wall Street wavers after rally, focus on inflation data	Nov. 13	RE
Medical device stocks rise in relief after Wegovy heart benefits data	Nov. 13	RE
Medical device makers rise on relief after Wegovy obesity trial data	Nov. 13	RE
Wall St falls as megacaps drag ahead of inflation data	Nov. 13	RE
Big tech saves the day	Nov. 13
ANALYST RECOMMENDATIONS : Airbnb, Apple, Best Buy, Diageo, Tesla...	Nov. 13
Corporate America weighs business impact of new weight-loss drugs	Nov. 13	RE
Dexcom Insider Sold Shares Worth $192,249, According to a Recent SEC Filing	Nov. 08	MT
Corporate America weighs business impact of new weight-loss drugs	Nov. 08	RE
Sector Update: Health Care Stocks Slip in Late Afternoon	Oct. 27	MT
Sector Update: Health Care Stocks Retreating in Afternoon Trading	Oct. 27	MT

More news

Analyst Recommendations on DexCom, Inc.

ANALYST RECOMMENDATIONS : Airbnb, Apple, Best Buy, Diageo, Tesla...	Nov. 13
UBS Raises DexCom Price Target to $145 From $138, Maintains Buy Rating	Oct. 27	MT
Piper Sandler Cuts Price Target on DexCom to $135 From $160, Maintains Overweight Rating	Oct. 27	MT
TD Cowen Cuts Price Target on DexCom to $110 From $150, Maintains Outperform Rating	Oct. 27	MT
Oppenheimer Adjusts DexCom Price Target to $122 From $150, Maintains Outperform Rating	Oct. 27	MT

More recommendations

News in other languages on DexCom, Inc.

Valores destacados al cierre del mercado norteamericano	Nov. 27
Las mejores acciones para ganar en bolsa en Wall Street en 2024	Nov. 20
Wall Street : biais encore positif avant les '3 sorcières'	Nov. 17
Wall Street : biais encore positif à la veille '3 sorcières'	Nov. 16
Dexcom dévoile une galerie de portraits pour dépeindre les hauts et les bas du quotidien avec le diabète à l'occasion de la Journée mondiale du diabète	Nov. 14

More news

Highs and lows

1 week

111.29

117.50

1 month

91.49

117.50

Current year

74.75

139.55

1 year

74.75

139.55

3 years

66.89

164.86

5 years

26.26

164.86

10 years

7.02

164.86

More quotes

Managers and Directors - DexCom, Inc.

Managers	Title	Age	Since
Kevin Sayer CEO	Chief Executive Officer	65	2007
Jereme Sylvain DFI	Director of Finance/CFO	43	2018
Girish Naganathan CTO	Chief Tech/Sci/R&D Officer	46	2022

Members of the board	Title	Age	Since
Mark Foletta BRD	Director/Board Member	62	2014
Eric Topol BRD	Director/Board Member	68	2009
Kevin Sayer CEO	Chief Executive Officer	65	2007

More insiders

ETFs positioned on DexCom, Inc.

Name	Weight	AuM	1st Jan change
VANECK BIONIC ENGINEERING UCITS ETF - USD	9.01%	4 M€	-.--%
VANECK GENOMICS AND HEALTHCARE INNOVATORS UCITS ETF - USD	6.15%	5 M€	-18.69%
GLOBAL X INTERNET OF THINGS UCITS ETF - USD	5.12%	3 M€	+7.59%
GLOBAL X INTERNET OF THINGS THEMATIC ETF - USD	5.11%	238 M€	+12.21%

More ETFs positioned on DexCom, Inc.

Quotes

Date	Price	Change	Volume
23-12-01	116.62	+0.95%	3,075,029
23-11-30	115.52	-0.57%	4,537,499
23-11-29	116.18	+3.55%	4,734,844
23-11-28	112.20	-1.56%	4,492,399
23-11-27	113.98	+0.91%	3,687,258

Delayed Quote Nasdaq, December 01, 2023 at 04:00 pm EST

More quotes

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 73.6% of net sales.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-02-07 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for DexCom, Inc.

Trading Rating :

Investor Rating :

ESG Refinitiv :

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

116.62USD

Average target price

125.37USD

Spread / Average Target

+7.51%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
DEXCOM, INC.	+2.98%	45 059 M $
ABBOTT LABORATORIES	-4.47%	182 B $
MEDTRONIC PLC	+2.92%	106 B $
BECTON, DICKINSON AND COMPANY	-6.31%	68 780 M $
CENCORA CORPORATION	+23.16%	40 616 M $
HOYA CORPORATION	+29.59%	39 198 M $
WEST PHARMACEUTICAL SERVICES, INC.	+49.48%	26 029 M $
ZIMMER BIOMET HOLDINGS, INC.	-7.47%	24 653 M $
METTLER-TOLEDO INTERNATIONAL, INC.	-23.59%	23 949 M $
TERUMO CORPORATION	+25.47%	23 774 M $

Other Medical Equipment, Supplies & Distribution

Sales 2023 *	3,592 M	Sales 2024 *	4,309 M	Capitalization	45.06 B
Net income 2023 *	443 M	Net income 2024 *	665 M	EV / Sales 2023 *	13,0x
Net Debt 2023 *	1,790 M	Net Debt 2024 *	1,107 M	EV / Sales 2024 *	10,7x
P/E ratio 2023 *	108x	P/E ratio 2024 *	71,5x	Employees	7,550
Yield 2023 *	-	Yield 2024 *	-	Free-Float	94.84%

Dexcom Announces Upcoming Conference Presentation	Nov. 21	BU
Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day	Nov. 14	BU
Historic Victory as People With Diabetes Win Access to Life-Changing Technology, But Almost Half Don’t Understand the Benefits1-2	Nov. 08	BU
DexCom: Q3 Earnings Snapshot	Oct. 26	AQ
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program	Oct. 26	BU

DexCom, Inc. Stock price

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Financials (USD)

Chart DexCom, Inc.

Latest news about DexCom, Inc.

Analyst Recommendations on DexCom, Inc.

Press releases DexCom, Inc.

News in other languages on DexCom, Inc.

Quotes and Performance

Highs and lows

Managers and Directors - DexCom, Inc.

ETFs positioned on DexCom, Inc.

Quotes

Company Profile

Income Statement Evolution

Ratings for DexCom, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

1 day	+0.95%
1 week	+3.25%
Current month	+0.95%
1 month	+24.50%
3 months	+14.45%
6 months	-4.85%
Current year	+2.98%